HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $17 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Cabaletta Bio (NASDAQ:CABA) and maintained a price target of $17.
October 04, 2023 | 10:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cabaletta Bio's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $17.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $17 indicates the firm's confidence in the stock's potential to reach this price, which could lead to an increase in investor interest and potentially a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100